These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Stimulation of prolactin release by vasoactive intestinal peptide (VIP). Ruberg M; Rotsztejn WH; Arancibia S; Besson J; Enjalbert A Eur J Pharmacol; 1978 Oct; 51(3):319-20. PubMed ID: 710507 [No Abstract] [Full Text] [Related]
10. [Dexamethasone regulation of the prolactin release induced by vasoactive intestinal peptide (VIP)]. Rotsztejn W; Benoist L; Besson J; Duval J C R Seances Acad Sci D; 1980 Mar; 290(12):791-3. PubMed ID: 6769606 [TBL] [Abstract][Full Text] [Related]
11. In vitro stimulation of prolactin release by vasoactive intestinal peptide. Samson WK; Said SI; Snyder G; McCann SM Peptides; 1980; 1(4):325-32. PubMed ID: 7301635 [TBL] [Abstract][Full Text] [Related]
12. The influence of vasoactive intestinal polypeptide and cholecystokinin on prolactin release in rat and human monolayer cultures. Malarkey WB; O'Dorisio TM; Kennedy M; Cataland S Life Sci; 1981 Jun; 28(22):2489-95. PubMed ID: 7253836 [No Abstract] [Full Text] [Related]
13. Vasoactive intestinal peptide: evidence for a hypothalamic site of action to release growth hormone, luteinizing hormone, and prolactin in conscious ovariectomized rats. Vijayan E; Samson WK; Said SI; McCann SM Endocrinology; 1979 Jan; 104(1):53-7. PubMed ID: 446354 [No Abstract] [Full Text] [Related]
14. Vasoactive intestinal polypeptide stimulation of cyclic AMP formation in rat central nervous system. Kaneko T; Nakaya S; Saito S; Yanaihara N; Oka H Endocrinol Jpn; 1980 Dec; 27 Suppl 1():7-10. PubMed ID: 6112141 [TBL] [Abstract][Full Text] [Related]
15. Effect of vasoactive intestinal peptide (VIP) on the release of adenohypophyseal hormones from purified cells obtained by unit gravity sedimentation. Inhibition by dexamethasone of vip-induced prolactin release. Rotsztejn WH; Benoist L; Besson J; Beraud G; Bluet-Pajot MT; Kordon C; Rosselin G; Duval J Neuroendocrinology; 1980 Oct; 31(4):282-6. PubMed ID: 7422069 [TBL] [Abstract][Full Text] [Related]
16. In GH3 pituitary cells, acetylcholine and vasoactive intestinal peptide antagonistically modulate adenylate cyclase, cyclic AMP content, and prolactin secretion. Onali P; Eva C; Olianas MC; Schwartz JP; Costa E Mol Pharmacol; 1983 Sep; 24(2):189-94. PubMed ID: 6310360 [TBL] [Abstract][Full Text] [Related]
17. Stimulation of in vitro prolactin release by vasoactive intestinal peptide. Enjalbert A; Arancibia S; Ruberg M; Priam M; Bluet-Pajot MT; Rotsztejn WH; Kordon C Neuroendocrinology; 1980 Sep; 31(3):200-4. PubMed ID: 7413020 [TBL] [Abstract][Full Text] [Related]
18. Regulation of G protein mRNA levels by thyroliberin, vasoactive intestinal peptide and somatostatin in prolactin-producing rat pituitary adenoma cells. Paulssen EJ; Paulssen RH; Haugen TB; Gautvik KM; Gordeladze JO Acta Physiol Scand; 1991 Oct; 143(2):195-201. PubMed ID: 1683738 [TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal peptide (VIP) stimulates prolactin (PRL) release and cAMP production in a rat pituitary cell line (GH3/B6). Additive effects of VIP and TRH on PRL release. Gourdji D; Bataille D; Vauclin N; Grouselle D; Rosselin G; Tixier-Vidal A FEBS Lett; 1979 Aug; 104(1):165-8. PubMed ID: 89971 [No Abstract] [Full Text] [Related]
20. Effects of growth hormone inhibiting factor (somatostatin) on the release of growth hormone and prolactin from pituitaries of the domestic fowl in vitro. Hall TR; Chadwick A J Endocrinol; 1976 Jan; 68(1):163-4. PubMed ID: 815507 [No Abstract] [Full Text] [Related] [Next] [New Search]